Four-days-on, three-days-off treatment regimen still looks effective after two years
Injectable HIV medications must be practical and affordable, conference hears
To be cost-effective, injectable PrEP can only cost about $3000 more than US generic oral PrEP
Gender-affirming surgery associated with sustained viral suppression
Doubling the dose of emergency contraception is a safe and effective way of overcoming efavirenz interaction
Every-other-month injectable cabotegravir and rilpivirine suppresses viral load for two years
Dolutegravir superior to standard-of-care treatment in children and adolescents
Targeted screening improves TB diagnosis in people with HIV in South Africa
Social networks key to PrEP uptake in rural Kenya and Uganda
